Neurexophilin-2 is a member of the neurexophilin family, which consists of small secreted proteins that are known to bind to neurexins. Neurexins serve as cell adhesion molecules in the nervous system and play a crucial role in the formation and function of synapses. Neurexophilin-2 in particular is believed to be involved in the intricate process of synaptic regulation and neurodevelopment. The expression of Neurexophilin-2 is a complex process, governed by a network of transcription factors, epigenetic modifications, and signaling pathways that can either promote or suppress its synthesis. Given its significance in the nervous system, the regulation of Neurexophilin-2 expression is of considerable interest, particularly in understanding the molecular underpinnings of neural function and the potential modulation of its expression.
In the realm of molecular biology, a variety of compounds have been identified that can modulate gene expression through diverse mechanisms. Compounds such as 5-Azacytidine could target the epigenetic machinery, potentially altering the methylation status of the DNA associated with the Neurexophilin-2 gene, leading to its transcriptional downregulation. Histone deacetylase inhibitors, like Vorinostat, may change the chromatin structure around the Neurexophilin-2 locus, resulting in a decrease in gene expression. Other compounds, such as Rapamycin, which interferes with the mTOR signaling pathway, could broadly reduce protein synthesis, including that of Neurexophilin-2. Similarly, inhibitors of the PI3K/AKT pathway, like LY294002, or MAPK/ERK pathway inhibitors like PD98059, could result in the reduced expression of Neurexophilin-2 by altering intracellular signaling cascades. Additionally, natural compounds such as Curcumin and Resveratrol have been shown to have broad regulatory effects on gene expression and might conceivably extend to the expression levels of Neurexophilin-2. These chemicals represent a spectrum of molecular entities that, through their interaction with various cellular processes, could serve as regulators of Neurexophilin-2 expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could demethylate DNA at the Neurexophilin-2 gene locus, potentially leading to a decrease in its transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may block histone deacetylase activity, resulting in hyperacetylation and subsequent repression of Neurexophilin-2 gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might bind retinoic acid receptors, which could downregulate transcription of genes including Neurexophilin-2 in neuronal tissue. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By specifically binding to mTOR, Rapamycin could lead to a reduction in cap-dependent translation, thereby decreasing Neurexophilin-2 synthesis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
This inhibitor might block PI3K activity, leading to a reduction in AKT signaling and consequently decreasing Neurexophilin-2 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibiting MEK with PD 98059 might result in a reduction of ERK pathway signaling, which could lead to decreased Neurexophilin-2 gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin could downregulate NF-κB signaling, which might result in the reduced transcription of Neurexophilin-2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol may activate sirtuins leading to deacetylation of transcription factors, possibly resulting in decreased Neurexophilin-2 expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
By inhibiting Smoothened, Cyclopamine might lead to the suppression of the Hedgehog signaling pathway, thereby reducing Neurexophilin-2 expression. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
DAPT could inhibit γ-secretase, leading to suppression of Notch receptor cleavage and a consequent decrease in Neurexophilin-2 expression. |